Home
Conditions
Waldenstrom Macroglobulinemia

Clinical trial condition

Waldenstrom Macroglobulinemia

Explore clinical trials studying Waldenstrom Macroglobulinemia. Study availability and eligibility vary by location and protocol.

394 public trials 46 recruiting studies

Refine in advanced search Browse all conditions

Waldenstrom Macroglobulinemia trial results

Recruiting

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

NCT06340737

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Recruiting

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

NCT00935090

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Recruiting

Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing

NCT06550427

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Recruiting

Clinical Study of the Hyperviscosity Syndrome in Waldenström Macroglobulinemia

NCT04898647

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: CHU Amiens Amiens, France

View Trial Details

Recruiting

Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM

NCT05914662

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia

NCT04061512

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Royal United Hospital, Bath Bath, United Kingdom

The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust Bournemouth, United Kingdom

East Kent Hospitals University NHS Foundation Trust Canterbury, United Kingdom

University Hospital of Wales Cardiff, United Kingdom

View all 25 locations

View Trial Details

Enrolling by Invitation

Watch and Wait or Worry and Wait in Indolent Lymphoma

NCT07173790

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
Locations: Samsung Medical Center Seoul, Gangnam-gu, South Korea

Korea UniversityKorea University Guro Hospital Seoul, Guro-gu, South Korea

Seoul National University Hospital Seoul, Jongno-gu, South Korea

The Catholic University of Korea Seoul, Seocho-gu, South Korea

View Trial Details

Not Yet Recruiting

Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy

NCT07711327

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +35 more
Locations: City of Hope Duarte, California, United States

UC San Diego Health San Diego, California, United States

Stanford Health Care Stanford, California, United States

View Trial Details

Not Yet Recruiting

ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia

NCT07420959

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Not Yet Recruiting

Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors

NCT07592481

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
Locations: Not specified

View Trial Details

Waldenstrom Macroglobulinemia

Waldenstrom Macroglobulinemia trial results

Related conditions